People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sterrx, Llc | — | Pharmaceuticals | Series A | $18.0M | $464.6M | 2017 |
Carl L Martin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Carl L Martin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gary L. Hanley | 1 | 1 |
| Terry L. Wiley | 1 | 1 |
| James, III L. McKee | 1 | 1 |
| Sandra L. Hawkins | 1 | 1 |
| Tana L. Hanley | 1 | 1 |
| Kent L Smeltz | 1 | 1 |
| Jeff L LaBombard | 1 | 1 |
| Vera L Delorme | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.